Anticancer drug R&D landscape in China
Open Access
- 13 May 2020
- journal article
- editorial
- Published by Springer Science and Business Media LLC in Journal of Hematology & Oncology
- Vol. 13 (1), 1-4
- https://doi.org/10.1186/s13045-020-00877-3
Abstract
No abstract availableThis publication has 3 references indexed in Scilit:
- Challenges in anticancer drug R&D in ChinaThe Lancet Oncology, 2019
- The global landscape of cancer cell therapyNature Reviews Drug Discovery, 2018
- Comprehensive analysis of the clinical immuno-oncology landscapeAnnals of Oncology, 2017